“Israel is perfectly positioned to enter and disrupt the medical cannabis market that is expected to soar to $33 billion worldwide in the next 5 years,” Saul Kaye, CEO of iCAN, an Israeli medical cannabis company, said in a statement.
“In Israel alone, we quickly expect over $1 billion in sales to countries interested in our products.”
Click here to read the complete article
Marcy Oster ~ JTA.org ~